CVS drug price overhaul ‘will likely be phased in over several years’, says Gabelli’s Jeff Jonas

Gabelli Healthcare & Wellness Trust Portfolio Manager Jeff Jonas joins CNBC on the news of CVS overhauling its drug pricing. Jeff also discusses his thoughts on weight-loss drugs and where to invest in the healthcare sector for 2024.